POXEL (EPA:POXEL) | WebDisclosure

Basculer en Français

8295	Companies
114858	Keywords
55302	Articles
62445	Press releases

Home
Companies
POXEL

BRIEF

published on 09/30/2024 at 07:35, 1 month 21 days ago

Poxel obtient un financement non dilutif de 50 millions de dollars auprès d'OrbiMed

Financement Non Dilutif TWYMEEG® Poxel Monétisation Des Redevances OrbiMed
BRIEF

published on 09/30/2024 at 07:35, 1 month 21 days ago

Poxel Secures $50M Non-Dilutive Financing from OrbiMed

Non-dilutive Financing TWYMEEG® Poxel Royalty Monetization OrbiMed
PRESS RELEASE

published on 09/30/2024 at 07:30, 1 month 21 days ago

Inside Information / Other news releases
Poxel monetizes TWYMEEG® royalties in a USD 50 million deal with OrbiMed. Proceeds to reduce debt and support rare disease activities. Webinars scheduled for investor updates

Webinars Royalties TWYMEEG® Poxel OrbiMed
BRIEF

published on 09/09/2024 at 07:35, 2 months 12 days ago

POXEL announces a significant increase in its sales in the second quarter of 2024

Sales Treasury Partnerships TWYMEEG® Poxel
BRIEF

published on 09/09/2024 at 07:35, 2 months 12 days ago

POXEL annonce une hausse significative de ses ventes au deuxième trimestre 2024

Partenariats Trésorerie Ventes TWYMEEG® Poxel
PRESS RELEASE

published on 09/09/2024 at 07:30, 2 months 12 days ago

Informations privilégiées / Autres communiqués
Poxel annonce ses chiffres pour le T2 et S1 2024, avec hausse des ventes de TWYMEEG® au Japon et bilan des activités. Discussions en cours pour monétisation des redevances et horizon financier solide

Chiffre D'affaires Japon Poxel TWYMEEG Redevances
BRIEF

published on 08/16/2024 at 08:16, 3 months 5 days ago

Poxel: Evolution of the Share Capital and the Number of Voting Rights

Share Capital Voting Rights Actions AMF Poxel
BRIEF

published on 08/16/2024 at 08:16, 3 months 5 days ago

Poxel : Évolution du Capital Social et du Nombre de Droits de Vote

Droits De Vote Capital Social Actions AMF Poxel
PRESS RELEASE

published on 08/16/2024 at 08:11, 3 months 5 days ago

Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Annonce du nombre d'actions et de droits de vote de Poxel, une société biopharmaceutique spécialisée dans les traitements contre les maladies métaboliques. Toutes les informations réglementées sont disponibles sur leur site web

Droits De Vote Actions Biopharmaceutique Maladies Métaboliques Poxel
BRIEF

published on 08/07/2024 at 08:05, 3 months 14 days ago

Sumitomo Pharma et Poxel dévoilent les résultats de l'étude sur le TWYMEEG® pour le diabète de type 2

Diabète De Type 2 Insuffisance Rénale TWYMEEG® Poxel Sumitomo Pharma

Accesswire

Published on 11/21/2024 at 12:00, 27 minutes ago

Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 27 minutes ago

Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 57 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 24 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 27 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 12:15, 12 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 20 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 27 minutes ago

Holding(s) in Company
Published on 11/21/2024 at 11:30, 57 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 1 hour 26 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen

Les Echos

Published on 11/21/2024 at 06:58, 5 hours 29 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 29 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 29 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 19 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 7 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE